The axis of HMGB1 and soluble RAGE levels in pleural effusions from various etiologies

被引：0
|
作者：
Kotsiou, Ourania
Jagirdar, Rajesh
Hatzoglou, Chrissi
Gourgoulianis, Konstantinos
Zarogiannis, Sotirios
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 50卷
关键词：
D O I：
10.1183/1393003.congress-2017.PA4295
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4295
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The Association of HMGB1 and RAGE Gene Polymorphisms with IgA Vasculitis
    Varga, Mateja Batnozic
    Held, Martina
    Wagner, Jasenka
    Arvaj, Nena
    Sestan, Mario
    Sapina, Matej
    Kifer, Nastasia
    Grguric, Danica
    Gornik, Kristina Crkvenac
    Gagro, Alenka
    Frkovic, Marijan
    Jelusic, Marija
    BIOCHEMICAL GENETICS, 2024, 62 (03) : 2268 - 2278
  • [32] Expression and Clinical Significance of HMGB1 and RAGE in Cervical Carcinoma
    Xiaoqin Du1
    Chinese Journal of Clinical Oncology, 2007, (05) : 343 - 346
  • [33] Analysis and targeting of HMGB1 and RAGE with heparin and heparan sulphates
    Rouhiainen, Ari
    Rauvala, Heikki
    INFLAMMATION RESEARCH, 2010, 59 : S86 - S87
  • [34] Soluble interleukin-6 receptor levels in pleural effusions
    Yokoyama, A
    Kohno, N
    Fujino, S
    Abe, M
    Ishida, O
    Hiwada, K
    RESPIRATORY MEDICINE, 1996, 90 (06) : 329 - 332
  • [35] Inhibition of HMGB1/RAGE axis suppressed the lipopolysaccharide (LPS)-induced vicious transformation of cervical epithelial cells
    You, Lifang
    Cui, Hongyin
    Zhao, Fen
    Sun, Huier
    Zhong, Huanxin
    Zhou, Guoli
    Chen, Xuejun
    BIOENGINEERED, 2021, 12 (01) : 4995 - 5003
  • [36] Increased HMGB1 serum levels and altered HMGB1 expression in patients with psoriasis vulgaris
    Chen, Tao
    Guo, Zai-pei
    Li, Li
    Wang, Ling
    Jia, Rui-zhen
    Cao, Na
    Qin, Sha
    Li, Meng-meng
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2013, 305 (03) : 263 - 267
  • [37] Soluble RAGE attenuates Ang II-induced arterial calcification via inhibiting AT1R-HMGB1-RAGE axis
    Jeong, Jisu
    Cho, Soyoung
    Seo, Miran
    Lee, Bok-Sim
    Jang, Yangsoo
    Lim, Soyeon
    Park, Sungha
    ATHEROSCLEROSIS, 2022, 346 : 53 - 62
  • [38] Use of single-point mutated HMGB1 box a variants as therapeutic agents in HMGB1 and rage related pathologies
    Lorenzetto, Chiara
    Fumero, Silvano
    Barone, Domenico
    Traversa, Silvio
    Guyon, Thierry
    Borrelly, Gilles
    INFLAMMATION RESEARCH, 2007, 56 : S190 - S190
  • [39] Correlation of soluble HMGB1 with MD-2 serum levels in dilated cardiomyopathy
    Kuemmel, A.
    Stohbach, A.
    Riad, A.
    Chamling, B.
    Gross, S.
    Doerr, M.
    Felix, S. B.
    Feldtmann, R.
    EUROPEAN HEART JOURNAL, 2018, 39 : 283 - 284
  • [40] Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
    Yang, Huan
    Liu, Hui
    Zeng, Qiong
    Imperato, Gavin H.
    Addorisio, Meghan E.
    Li, Jianhua
    He, Mingzhu
    Cheng, Kai Fan
    Al-Abed, Yousef
    Harris, Helena E.
    Chavan, Sangeeta S.
    Andersson, Ulf
    Tracey, Kevin J.
    MOLECULAR MEDICINE, 2019, 25 (1)
12345